These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6345378)

  • 1. Factors influencing the hypotensive effects of calcium antagonists.
    Erne P; Bolli P; Bertel O; Hulthen UL; Kiowski W; Muller FB; Buhler F
    Hypertension; 1983; 5(4 Pt 2):II97-102. PubMed ID: 6345378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium blockade in arterial hypertension. Review.
    Lederballe Pedersen O
    Hypertension; 1983; 5(4 Pt 2):II74-9. PubMed ID: 6222972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension.
    Binggeli C; Corti R; Sudano I; Luscher TF; Noll G
    Hypertension; 2002 Apr; 39(4):892-6. PubMed ID: 11967245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists: a potent vasodilatory principle and alternative basic antihypertensive therapy].
    Bolli P; Erne P; Bühler FR
    Schweiz Med Wochenschr; 1983 Nov; 113(46):1733-5. PubMed ID: 6658418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the hypotensive effects of finoptin and corinfar after their sublingual administration].
    Kolesova MA; Orlov VM
    Klin Med (Mosk); 1988 Feb; 66(2):38-41. PubMed ID: 3286995
    [No Abstract]   [Full Text] [Related]  

  • 10. Similarities and differences in the antihypertensive effect of two calcium antagonist drugs, verapamil and nifedipine.
    Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Corea L; Muiesan G
    J Am Coll Cardiol; 1986 Apr; 7(4):916-24. PubMed ID: 3514729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.
    Saseen JJ; Carter BL; Brown TE; Elliott WJ; Black HR
    Hypertension; 1996 Jul; 28(1):109-14. PubMed ID: 8675249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypertension with calcium antagonists. Review.
    Guazzi MD; Polese A; Fiorentini C; Bartorelli A; Moruzzi P
    Hypertension; 1983; 5(4 Pt 2):II85-90. PubMed ID: 6222973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists in the therapy of hypertension].
    Heidland A; Heidbreder E; Hörl WH; Schäfer RM
    Klin Wochenschr; 1983 Jul; 61(13):633-40. PubMed ID: 6350692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Castellano M; Alicandri CL; Corea L; Fariello R; Beschi M; Romanelli G
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S325-9. PubMed ID: 6184562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists.
    Muiesan G; Agabiti-Rosei E; Romanelli G; Muiesan ML; Castellano M; Beschi M
    Am J Cardiol; 1986 Feb; 57(7):44D-49D. PubMed ID: 3006466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers.
    Massie BM
    Am J Cardiol; 1985 Dec; 56(16):97H-100H. PubMed ID: 2866709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does renin determine the blood pressure response to calcium entry blockers?
    Waeber B; Nussberger J; Brunner HR
    Hypertension; 1985; 7(2):223-7. PubMed ID: 3884503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.